Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.
Kang S, Leyden JJ, Lowe NJ, Ortonne JP, Phillips TJ, Weinstein GD, Bhawan J, Lew-Kaya DA, Matsumoto RM, Sefton J, Walker PS, Gibson JR. Kang S, et al. Among authors: sefton j. Arch Dermatol. 2001 Dec;137(12):1597-604. doi: 10.1001/archderm.137.12.1597. Arch Dermatol. 2001. PMID: 11735710 Clinical Trial.
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
Weinstein GD, Koo JY, Krueger GG, Lebwohl MG, Lowe NJ, Menter MA, Lew-Kaya DA, Sefton J, Gibson JR, Walker PS; Tazarotene Cream Clinical Study Group. Weinstein GD, et al. Among authors: sefton j. J Am Acad Dermatol. 2003 May;48(5):760-7. doi: 10.1067/mjd.2003.103. J Am Acad Dermatol. 2003. PMID: 12734506 Clinical Trial.
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.
Weinstein GD, Krueger GG, Lowe NJ, Duvic M, Friedman DJ, Jegasothy BV, Jorizzo JL, Shmunes E, Tschen EH, Lew-Kaya DA, Lue JC, Sefton J, Gibson JR, Chandraratna RA. Weinstein GD, et al. Among authors: sefton j. J Am Acad Dermatol. 1997 Jul;37(1):85-92. doi: 10.1016/s0190-9622(97)70216-0. J Am Acad Dermatol. 1997. PMID: 9216528 Clinical Trial.
Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR; Tazarotene Cream in Acne Clinical Study Investigator Group. Shalita AR, et al. Among authors: sefton j. Clin Ther. 2004 Nov;26(11):1865-73. doi: 10.1016/j.clinthera.2004.11.012. Clin Ther. 2004. PMID: 15639698
Response of psoriasis to a new topical retinoid, AGN 190168.
Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, Sefton J, Duvic M. Esgleyes-Ribot T, et al. Among authors: sefton j. J Am Acad Dermatol. 1994 Apr;30(4):581-90. doi: 10.1016/s0190-9622(94)70066-4. J Am Acad Dermatol. 1994. PMID: 7512583 Clinical Trial.
99 results